Letter to the Editor

Page 8

Recently published articles about Letter to the Editor

PCC
Neuropsychiatric Manifestations of Mpox
Letter to the Editor

April 18, 2023

Rujittika Mungmunpuntipantip, PhD, and Viroj Wiwanitkit, MD, comment on a report recently published in the PCC.
,
PCC
Lurasidone-Induced Urinary Retention
Letter to the Editor

April 4, 2023

Gregory M. Asnis, MD, comments on a report recently published in the PCC.
PCC
Comment on Huntington’s Disease With Psychotic Features
Letter to the Editor

March 7, 2023

Herwig Lange, MD, comments on a report previously published in the PCC.
PCC
State of the Art of Diagnostics and Genetics in Huntington’s Chorea
Letter to the Editor

March 7, 2023

Mayank Gupta, MD, and Christoph U. Correll, MD, respond to Herwig Lange, MD, regarding their previous case report of a patient with Huntington’s disease.
,
PCC
Buprenorphine Maintenance in the Fentanyl Era
Letter to the Editor

February 14, 2023

Methods to foster patient adherence and physician acceptability of buprenorphine maintenance are needed to incorporate this treatment into primary care for fentanyl users.
,
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
, ,
JCP
Pregnancy Outcomes After SGA Exposure: Extracting More From the Data
Letter to the Editor

November 30, 2022

Malathi Perugula, MD, and colleagues call attention to design aspects of a recent study on antipsychotic use in pregnancy.
, , , et al
JCP
Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy
Letter to the Editor

November 30, 2022

Naho Yakuwa, BPharm, responds to Perugula and colleagues about a recent study on SGA use during early pregnancy.
JCP
Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too
Letter to the Editor

November 28, 2022

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical research.
JCP
Valproate Prescribing in Individuals of Childbearing Age
Letter to the Editor

October 12, 2022

Camille Tastenhoye, MD, and colleagues share data from a tertiary care women’s hospital that highlight opportunities for improvement in valproate prescribing practices.
, , , et al
JCP
Addressing the Problem of Prescription of Valproate to Women of Childbearing Age: Reply to Tastenhoye et al
Letter to the Editor

October 12, 2022

Chittaranjan Andrade, MD, responds to a letter by Tastenhoye et al and comments on his recent study on valproate prescription in women.
JCP
Asenapine, Aggression, and Affinity
Letter to the Editor

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe